← Indications
Landscape

Auditory Neuropathy

Auditory Neuropathy has 10 tracked records across 9 named organizations, including 3 strong-evidence records and 1 active programs. Records with caveats and trial-derived candidates remain visible for deeper review.

Open filtered programs
10
Pipeline Records
strong evidence + caveats + candidates
3
Strong Evidence
7 checked records with caveats
1
Active Programs
currently active
8
Marketed / Approved
commercial or approved
9
Organizations
companies, sponsors, and institutions
Competitive Density
25/100
organization breadth + program volume
Pipeline Velocity
34/100
active and late-stage share
Evidence Coverage
30/100
share strong evidence
Completion Signal
100/100
late-stage, approved, or marketed
Attrition Rate
10/100
share discontinued
Concentration
20/100
top-organization share

Programs by Stage

Preclinical1 · 10%
Approved2 · 20%
Marketed7 · 70%

Trial / Program Status

Active1 · 10%
Marketed6 · 60%
Approved2 · 20%
Discontinued1 · 10%

Modality Breakdown

Diagnostic6 · 60%
BCI/Neurotech4 · 40%

Program Types

Diagnostic6 · 60%
Device3 · 30%
Software/Neurotech1 · 10%

Top Organizations

Interacoustics2 · 20%
Cochlear1 · 10%
Grason-Stadler1 · 10%
Institution-led study1 · 10%
MED-EL1 · 10%
Natus1 · 10%
Oticon Medical1 · 10%
Otodynamics1 · 10%

Population Tags

adult8 · 80%
pediatric8 · 80%
congenital7 · 70%
auditory-brainstem-implant3 · 30%
implantable-neuroprosthesis3 · 30%
profound3 · 30%
clinical-audiology2 · 20%
newborn-screening2 · 20%
portable-diagnostics2 · 20%
central-auditory-prosthesis1 · 10%